https://stock.noler.com/us/stock/turning-point-therapeutics-inc https://stock.noler.com/us/stock/turning-point-therapeutics-inc/accounts-payable https://stock.noler.com/us/stock/turning-point-therapeutics-inc/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/turning-point-therapeutics-inc/accumulated-depreciation https://stock.noler.com/us/stock/turning-point-therapeutics-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/turning-point-therapeutics-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/turning-point-therapeutics-inc/amortization-of-leased-asset https://stock.noler.com/us/stock/turning-point-therapeutics-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/turning-point-therapeutics-inc/aoci https://stock.noler.com/us/stock/turning-point-therapeutics-inc/available-for-sale-current https://stock.noler.com/us/stock/turning-point-therapeutics-inc/available-for-sale-debt-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/turning-point-therapeutics-inc/available-for-sale-debt-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/turning-point-therapeutics-inc/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/turning-point-therapeutics-inc/available-for-sale-debt-securities https://stock.noler.com/us/stock/turning-point-therapeutics-inc/available-for-sale-debt-transfer-to-held-to-maturity-allowance-for-credit-loss-expense https://stock.noler.com/us/stock/turning-point-therapeutics-inc/basic-shares https://stock.noler.com/us/stock/turning-point-therapeutics-inc/capital-expenditures https://stock.noler.com/us/stock/turning-point-therapeutics-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/turning-point-therapeutics-inc/cash-and-cash-equivalents-fair-value-disclosure https://stock.noler.com/us/stock/turning-point-therapeutics-inc/cash-and-equivalents https://stock.noler.com/us/stock/turning-point-therapeutics-inc/cash-and-restricted-cash-including-disposal-group-and-discontinued-operations https://stock.noler.com/us/stock/turning-point-therapeutics-inc/cash-cash-equivalents-and-short-term-investments https://stock.noler.com/us/stock/turning-point-therapeutics-inc/cash-flow-breakdown https://stock.noler.com/us/stock/turning-point-therapeutics-inc/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/turning-point-therapeutics-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/turning-point-therapeutics-inc/common-stock-value https://stock.noler.com/us/stock/turning-point-therapeutics-inc/comprehensive-income https://stock.noler.com/us/stock/turning-point-therapeutics-inc/convertible-preferred-stock-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/turning-point-therapeutics-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/turning-point-therapeutics-inc/current-assets https://stock.noler.com/us/stock/turning-point-therapeutics-inc/current-liabilities https://stock.noler.com/us/stock/turning-point-therapeutics-inc/deferred-compensation-arrangement-with-individual-shares-authorized-for-issuance https://stock.noler.com/us/stock/turning-point-therapeutics-inc/deferred-finance-costs-net https://stock.noler.com/us/stock/turning-point-therapeutics-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/turning-point-therapeutics-inc/deferred-rent-credit-noncurrent https://stock.noler.com/us/stock/turning-point-therapeutics-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/turning-point-therapeutics-inc/deferred-tax-assets-in-process-research-and-development https://stock.noler.com/us/stock/turning-point-therapeutics-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/turning-point-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/turning-point-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards-domestic https://stock.noler.com/us/stock/turning-point-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards-state-and-local https://stock.noler.com/us/stock/turning-point-therapeutics-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/turning-point-therapeutics-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/turning-point-therapeutics-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/turning-point-therapeutics-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/turning-point-therapeutics-inc/deferred-tax-liabilities-leasing-arrangements https://stock.noler.com/us/stock/turning-point-therapeutics-inc/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/turning-point-therapeutics-inc/defined-contribution-plan-cost-recognized https://stock.noler.com/us/stock/turning-point-therapeutics-inc/depreciation https://stock.noler.com/us/stock/turning-point-therapeutics-inc/diluted-shares https://stock.noler.com/us/stock/turning-point-therapeutics-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/turning-point-therapeutics-inc/effective-tax-rate https://stock.noler.com/us/stock/turning-point-therapeutics-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/turning-point-therapeutics-inc/employee-stock-ownership-plan-esop-number-of-allocated-shares https://stock.noler.com/us/stock/turning-point-therapeutics-inc/eps https://stock.noler.com/us/stock/turning-point-therapeutics-inc/eps-basic https://stock.noler.com/us/stock/turning-point-therapeutics-inc/financing-cash-flow https://stock.noler.com/us/stock/turning-point-therapeutics-inc/form-d-stocks https://stock.noler.com/us/stock/turning-point-therapeutics-inc/general-and-administrative-expense https://stock.noler.com/us/stock/turning-point-therapeutics-inc/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/turning-point-therapeutics-inc/income-tax https://stock.noler.com/us/stock/turning-point-therapeutics-inc/income-taxes-paid https://stock.noler.com/us/stock/turning-point-therapeutics-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/turning-point-therapeutics-inc/increase-decrease-in-accrued-liabilities-and-other-operating-liabilities https://stock.noler.com/us/stock/turning-point-therapeutics-inc/increase-decrease-in-employee-related-liabilities https://stock.noler.com/us/stock/turning-point-therapeutics-inc/increase-decrease-in-other-current-assets https://stock.noler.com/us/stock/turning-point-therapeutics-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/turning-point-therapeutics-inc/increase-decrease-in-security-deposits https://stock.noler.com/us/stock/turning-point-therapeutics-inc/incremental-common-shares-attributable-to-conversion-of-preferred-stock https://stock.noler.com/us/stock/turning-point-therapeutics-inc/insider-transactions-preferred https://stock.noler.com/us/stock/turning-point-therapeutics-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/turning-point-therapeutics-inc/interest-income-expense-net https://stock.noler.com/us/stock/turning-point-therapeutics-inc/investing-cash-flow https://stock.noler.com/us/stock/turning-point-therapeutics-inc/lessee-operating-lease-discount-rate https://stock.noler.com/us/stock/turning-point-therapeutics-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/turning-point-therapeutics-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/turning-point-therapeutics-inc/marketable-securities https://stock.noler.com/us/stock/turning-point-therapeutics-inc/marketable-securities-current https://stock.noler.com/us/stock/turning-point-therapeutics-inc/marketable-securities-unrealized-gain-loss https://stock.noler.com/us/stock/turning-point-therapeutics-inc/money-market-funds-at-carrying-value https://stock.noler.com/us/stock/turning-point-therapeutics-inc/net-change-in-cash https://stock.noler.com/us/stock/turning-point-therapeutics-inc/net-income https://stock.noler.com/us/stock/turning-point-therapeutics-inc/number-of-operating-segments https://stock.noler.com/us/stock/turning-point-therapeutics-inc/oci-net-of-tax https://stock.noler.com/us/stock/turning-point-therapeutics-inc/oci-unrealized-holding-gain-loss-on-securities-arising-net-of-tax https://stock.noler.com/us/stock/turning-point-therapeutics-inc/operating-cash-flow https://stock.noler.com/us/stock/turning-point-therapeutics-inc/operating-expenses https://stock.noler.com/us/stock/turning-point-therapeutics-inc/operating-income https://stock.noler.com/us/stock/turning-point-therapeutics-inc/operating-lease-assets https://stock.noler.com/us/stock/turning-point-therapeutics-inc/operating-lease-cost https://stock.noler.com/us/stock/turning-point-therapeutics-inc/operating-lease-expense https://stock.noler.com/us/stock/turning-point-therapeutics-inc/operating-lease-liability https://stock.noler.com/us/stock/turning-point-therapeutics-inc/operating-lease-liability-current https://stock.noler.com/us/stock/turning-point-therapeutics-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/turning-point-therapeutics-inc/operating-lease-payments https://stock.noler.com/us/stock/turning-point-therapeutics-inc/operating-lease-payments-due https://stock.noler.com/us/stock/turning-point-therapeutics-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/turning-point-therapeutics-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/turning-point-therapeutics-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/turning-point-therapeutics-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/turning-point-therapeutics-inc/operating-lease-payments-due-next-rolling-twelve-months https://stock.noler.com/us/stock/turning-point-therapeutics-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/turning-point-therapeutics-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/turning-point-therapeutics-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/turning-point-therapeutics-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/turning-point-therapeutics-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/turning-point-therapeutics-inc/operating-lease-right-of-use-asset-amortization-expense https://stock.noler.com/us/stock/turning-point-therapeutics-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/turning-point-therapeutics-inc/operating-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/turning-point-therapeutics-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/turning-point-therapeutics-inc/other-current-liabilities https://stock.noler.com/us/stock/turning-point-therapeutics-inc/other-noncurrent-assets https://stock.noler.com/us/stock/turning-point-therapeutics-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/turning-point-therapeutics-inc/other-operating-income https://stock.noler.com/us/stock/turning-point-therapeutics-inc/other-than-temporary-impairment-loss-debt-securities-available-for-sale https://stock.noler.com/us/stock/turning-point-therapeutics-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/turning-point-therapeutics-inc/payments-of-financing-costs https://stock.noler.com/us/stock/turning-point-therapeutics-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/turning-point-therapeutics-inc/payments-to-acquire-available-for-sale-securities https://stock.noler.com/us/stock/turning-point-therapeutics-inc/payments-to-acquire-marketable-securities https://stock.noler.com/us/stock/turning-point-therapeutics-inc/preferred-shares-facts https://stock.noler.com/us/stock/turning-point-therapeutics-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/turning-point-therapeutics-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/turning-point-therapeutics-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/turning-point-therapeutics-inc/preferred-stock-value https://stock.noler.com/us/stock/turning-point-therapeutics-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/turning-point-therapeutics-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/turning-point-therapeutics-inc/proceeds-from-issuance-of-convertible-preferred-stock https://stock.noler.com/us/stock/turning-point-therapeutics-inc/proceeds-from-sale-and-maturity-of-marketable-securities https://stock.noler.com/us/stock/turning-point-therapeutics-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/turning-point-therapeutics-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/turning-point-therapeutics-inc/proceeds-from-stock-plans https://stock.noler.com/us/stock/turning-point-therapeutics-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/turning-point-therapeutics-inc/property-plant-equipment https://stock.noler.com/us/stock/turning-point-therapeutics-inc/public-float https://stock.noler.com/us/stock/turning-point-therapeutics-inc/related-party-transaction-due-from-to-related-party https://stock.noler.com/us/stock/turning-point-therapeutics-inc/related-party-transaction-purchases-from-related-party https://stock.noler.com/us/stock/turning-point-therapeutics-inc/research-and-development https://stock.noler.com/us/stock/turning-point-therapeutics-inc/retained-earnings https://stock.noler.com/us/stock/turning-point-therapeutics-inc/revenue https://stock.noler.com/us/stock/turning-point-therapeutics-inc/revenue-remaining-performance-obligation https://stock.noler.com/us/stock/turning-point-therapeutics-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/turning-point-therapeutics-inc/security-deposit https://stock.noler.com/us/stock/turning-point-therapeutics-inc/shareholders-equity https://stock.noler.com/us/stock/turning-point-therapeutics-inc/shares-authorized https://stock.noler.com/us/stock/turning-point-therapeutics-inc/shares-issued https://stock.noler.com/us/stock/turning-point-therapeutics-inc/shares-issued-price-per-share https://stock.noler.com/us/stock/turning-point-therapeutics-inc/shares-issued-shares-new-issues https://stock.noler.com/us/stock/turning-point-therapeutics-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/turning-point-therapeutics-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/turning-point-therapeutics-inc/stock-award-fair-value-assumptions-expected-volatility-rate-maximum https://stock.noler.com/us/stock/turning-point-therapeutics-inc/stock-award-fair-value-assumptions-expected-volatility-rate-minimum https://stock.noler.com/us/stock/turning-point-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/turning-point-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-maximum https://stock.noler.com/us/stock/turning-point-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-minimum https://stock.noler.com/us/stock/turning-point-therapeutics-inc/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/turning-point-therapeutics-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/turning-point-therapeutics-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/turning-point-therapeutics-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/turning-point-therapeutics-inc/stock-award-rsu-forfeited-in-period https://stock.noler.com/us/stock/turning-point-therapeutics-inc/stock-award-rsu-forfeitures-grant-date-fair-value https://stock.noler.com/us/stock/turning-point-therapeutics-inc/stock-award-rsu-grants-in-period https://stock.noler.com/us/stock/turning-point-therapeutics-inc/stock-award-rsu-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/turning-point-therapeutics-inc/stock-award-rsu-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/turning-point-therapeutics-inc/stock-award-rsu-nonvested-number https://stock.noler.com/us/stock/turning-point-therapeutics-inc/stock-award-rsu-vested-in-period https://stock.noler.com/us/stock/turning-point-therapeutics-inc/stock-award-rsu-vested-in-period-grant-date-fair-value https://stock.noler.com/us/stock/turning-point-therapeutics-inc/stock-based-compensation https://stock.noler.com/us/stock/turning-point-therapeutics-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/turning-point-therapeutics-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/turning-point-therapeutics-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/turning-point-therapeutics-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/turning-point-therapeutics-inc/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/turning-point-therapeutics-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/turning-point-therapeutics-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/turning-point-therapeutics-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/turning-point-therapeutics-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/turning-point-therapeutics-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/turning-point-therapeutics-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/turning-point-therapeutics-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/turning-point-therapeutics-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/turning-point-therapeutics-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/turning-point-therapeutics-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/turning-point-therapeutics-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/turning-point-therapeutics-inc/stock-options-vested-and-expected-to-vest-exercisable-average-exercise-price https://stock.noler.com/us/stock/turning-point-therapeutics-inc/stock-options-vested-and-expected-to-vest-exercisable-number https://stock.noler.com/us/stock/turning-point-therapeutics-inc/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/turning-point-therapeutics-inc/stock-split-ratio https://stock.noler.com/us/stock/turning-point-therapeutics-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/turning-point-therapeutics-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/turning-point-therapeutics-inc/tax-rate-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/turning-point-therapeutics-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/turning-point-therapeutics-inc/tax-rate-reconciliation-other-reconciling-items-percent https://stock.noler.com/us/stock/turning-point-therapeutics-inc/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/turning-point-therapeutics-inc/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/turning-point-therapeutics-inc/temporary-equity-carrying-amount-attributable-to-parent https://stock.noler.com/us/stock/turning-point-therapeutics-inc/temporary-equity-liquidation-preference https://stock.noler.com/us/stock/turning-point-therapeutics-inc/temporary-equity-par-or-stated-value-per-share https://stock.noler.com/us/stock/turning-point-therapeutics-inc/temporary-equity-shares-authorized https://stock.noler.com/us/stock/turning-point-therapeutics-inc/temporary-equity-shares-issued https://stock.noler.com/us/stock/turning-point-therapeutics-inc/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/turning-point-therapeutics-inc/total-assets https://stock.noler.com/us/stock/turning-point-therapeutics-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/turning-point-therapeutics-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/turning-point-therapeutics-inc/utb-decrease-from-prior-year-positions https://stock.noler.com/us/stock/turning-point-therapeutics-inc/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/turning-point-therapeutics-inc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/turning-point-therapeutics-inc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/turning-point-therapeutics-inc/utb-that-would-impact-effective-tax-rate https://stock.noler.com/us/stock/turning-point-therapeutics-inc/variable-lease-cost https://stock.noler.com/us/stock/turning-point-therapeutics-inc/weighted-average-number-of-share-outstanding-basic-and-diluted